Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.6443
+0.0213 (3.42%)
At close: Apr 24, 2026, 4:00 PM EDT
0.6781
+0.0338 (5.25%)
After-hours: Apr 24, 2026, 6:11 PM EDT
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $15.14 million as of April 24, 2026. Its market cap has increased by 29.85% in one year.
Market Cap
15.14M
Enterprise Value
14.93M
1-Year Change
29.85%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $15.14M, a decrease of -65.59%. That is a compound annual growth rate of -56.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 14.64M | 61.45% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 819.65B |
| Johnson & Johnson | 542.95B |
| AbbVie | 359.93B |
| UnitedHealth Group | 324.89B |
| Lipocine | 17.15M |
| SeaStar Medical Holding | 17.01M |
| NewcelX | 16.96M |
| Wellgistics Health | 16.74M |